Contact

Cantabio Pharmaceuticals Inc.

2225 East Bayshore Road
Palo Alto, CA 94303

Main Office: 844-200-2826
info@cantabio.com

Investor Relations
(844) 200-CTBO
ir@cantabio.com

Latest News

Nov 13, 2019 Cantabio Announces Publication of Novel Study Demonstrating the Importance of the DJ-1 Protein in the Onset and Pathology of Alzheimer's and Parkinson's disease

About

Cantabio Pharmaceuticals Inc. conducts novel and innovative research, which is yielding a discovery pipeline and is focused on bringing drug candidates to clinical trials. These approaches are applicable to Parkinson’s, Alzheimer’s and other related neurodegenerative diseases.

Learn More